doi:10.1016/j.spinee.2014.10.011 6 Bartleson JD, Maus TP
A 24-year-old patient with ankylosing spondylitis and refractory vitiligo improved significantly following six months of infliximab therapy at a dose of 5mg/kg intravenously in weeks 0, 2, and 6, and then every eight weeks for ten months (24)
The commenter believes that the vMap procedure meets the New Technology APC criteria based on the demonstrated costs of the procedure and that there is precedent for SaaS technologies
Therefore defects in inducing apoptosis could lead to the persistence of autoreactive T- or B-cells [95]
Furthermore, overexpression of GSTs in many tumors is frequently associated with drug resistance phenotypes
Norden-Krichmar TM, Rotroff D, Schwantes-An TH, Bataller R, Goldman D, Nagy LE, et al